Global L-Phenylalanine

L-Phenylalanine Comprehensive Study by Type (Food Grade, Pharmaceutical Grade, Nutraceutical, Industrial Grade), Application (Food, Medicine, Supplements, Others), End-User (Pharmacy Shops/Retailers, Hospitals and Clinics, Gyms and Fitness Centers), Distribution Channel (Online, Offline), Different Treatments (Depression, Attention Deficit-Hyperactivity Disorder, Parkinson's Disease, Chronic Pain, Osteoarthritis, Rheumatoid Arthritis) Players and Region - Global Market Outlook to 2030

L-Phenylalanine Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About L-Phenylalanine
L-Phenylalanine is an essential type of amino acid. It refers to the building block of protein. It used in food supplements, medicinal use, industrial use. It is an only single amino acid found in proteins, it is found in food products like meat, fish, eggs, cheese, and milk. Used to treat various diseases and disorders such as skin disease called vitiligo, Parkinson’s, RA, alcohol withdrawal symptoms, weight loss therapy.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The essential nutrient market is growing day by day as the changing lifestyle required more health-focused products nowadays. The top leading firms are ruling the market and there is the perfect competition between top leading firms with their respective products. The mergers and acquisitions are not so taken into consideration in this market specifically in recent years. Analyst at AMA Research estimates that China Vendors will contribute the maximum growth to Global L-Phenylalanine market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Ajinomoto (Japan), Kyowa Hakko Bio (India), Hebei Huayang Biological Technology Co (China), Wuxi Jinghai Amino Acid Co Ltd (China), Zhangjiagang Huachang Pharmaceutical (China), Livzon Pharmaceutical Group (China), Piping Rock (United States), Twinlab Consolidated Corporation (United States), Solgar (United States) and BlueBonnet (United States) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Jiahe Biotech (China), Xiyue Pharmaceuticals (China) and Others.

Segmentation Overview
AMA Research has segmented the market of Global L-Phenylalanine market by Type (Food Grade, Pharmaceutical Grade, Nutraceutical and Industrial Grade), Application (Food, Medicine, Supplements and Others) and Region.



On the basis of geography, the market of L-Phenylalanine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-User , the sub-segment i.e. Pharmacy Shops/Retailers will boost the L-Phenylalanine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the L-Phenylalanine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Different Treatments, the sub-segment i.e. Depression will boost the L-Phenylalanine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
It is Highly Demanded as Supplement as Only Amino Acids Have Proteins

Market Growth Drivers:
Growing Use in Market as it is Consider One of the Essential Amino Acids and Demanded on Large Scale as it Helps Reduce Mild Pain Symptoms, Joint Discomfort, And Even Out Skin Tone

Challenges:
Individual Avoid Use if Have Condition Called Schizophrenia and High Cost Associated With Product

Restraints:
Highly Reactive With Antipsychotic Medicines

Opportunities:
Highly Used in Weight Loss Therapy

Market Leaders and their expansionary development strategies
In April, Ajinomoto acquired all the capital stock of Althea at closing for a purchase price of approximately USD175 million dollars (USD). Althea will become a fully consolidated subsidiary of Ajinomoto Co., Inc. operating under the company name Ajinomoto Althea, Inc.
In September 2018 BLueBonnet company launch its upgraded simply calm powder mixture of magnesium carbonate/citrate delivering one of the highest levels of elemental magnesium per saving (420mg) to treat occasional sleeplessness, stress, and bone immune system.
The US FDA Code of Federal Regulations regulates amino acids and its derivatives used for food and medicinal use. The guideline falls under this regulation are –, • The name of the amino acid(s) should contain the specific optical and chemical form and • The amounts of each amino acid contained in any mixture

Key Target Audience
Raw material suppliers, Distributors/traders/wholesalers/suppliers, Regulatory bodies, Government agencies and NGO, Research and development institutions, Government organizations, Trade associations and industry bodies and End-use industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Food Grade
  • Pharmaceutical Grade
  • Nutraceutical
  • Industrial Grade
By Application
  • Food
  • Medicine
  • Supplements
  • Others
By End-User
  • Pharmacy Shops/Retailers
  • Hospitals and Clinics
  • Gyms and Fitness Centers

By Distribution Channel
  • Online
  • Offline

By Different Treatments
  • Depression
  • Attention Deficit-Hyperactivity Disorder
  • Parkinson's Disease
  • Chronic Pain
  • Osteoarthritis
  • Rheumatoid Arthritis

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Use in Market as it is Consider One of the Essential Amino Acids
      • 3.2.2. Demanded on Large Scale as it Helps Reduce Mild Pain Symptoms, Joint Discomfort, And Even Out Skin Tone
    • 3.3. Market Challenges
      • 3.3.1. Individual Avoid Use if Have Condition Called Schizophrenia
      • 3.3.2. High Cost Associated With Product
    • 3.4. Market Trends
      • 3.4.1. It is Highly Demanded as Supplement as Only Amino Acids Have Proteins
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global L-Phenylalanine, by Type, Application, End-User , Distribution Channel, Different Treatments and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global L-Phenylalanine (Value)
      • 5.2.1. Global L-Phenylalanine by: Type (Value)
        • 5.2.1.1. Food Grade
        • 5.2.1.2. Pharmaceutical Grade
        • 5.2.1.3. Nutraceutical
        • 5.2.1.4. Industrial Grade
      • 5.2.2. Global L-Phenylalanine by: Application (Value)
        • 5.2.2.1. Food
        • 5.2.2.2. Medicine
        • 5.2.2.3. Supplements
        • 5.2.2.4. Others
      • 5.2.3. Global L-Phenylalanine by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global L-Phenylalanine by: Different Treatments (Value)
        • 5.2.4.1. Depression
        • 5.2.4.2. Attention Deficit-Hyperactivity Disorder
        • 5.2.4.3. Parkinson's Disease
        • 5.2.4.4. Chronic Pain
        • 5.2.4.5. Osteoarthritis
        • 5.2.4.6. Rheumatoid Arthritis
      • 5.2.5. Global L-Phenylalanine Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global L-Phenylalanine (Volume)
      • 5.3.1. Global L-Phenylalanine by: Type (Volume)
        • 5.3.1.1. Food Grade
        • 5.3.1.2. Pharmaceutical Grade
        • 5.3.1.3. Nutraceutical
        • 5.3.1.4. Industrial Grade
      • 5.3.2. Global L-Phenylalanine by: Application (Volume)
        • 5.3.2.1. Food
        • 5.3.2.2. Medicine
        • 5.3.2.3. Supplements
        • 5.3.2.4. Others
      • 5.3.3. Global L-Phenylalanine by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global L-Phenylalanine by: Different Treatments (Volume)
        • 5.3.4.1. Depression
        • 5.3.4.2. Attention Deficit-Hyperactivity Disorder
        • 5.3.4.3. Parkinson's Disease
        • 5.3.4.4. Chronic Pain
        • 5.3.4.5. Osteoarthritis
        • 5.3.4.6. Rheumatoid Arthritis
      • 5.3.5. Global L-Phenylalanine Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global L-Phenylalanine (Price)
      • 5.4.1. Global L-Phenylalanine by: Type (Price)
  • 6. L-Phenylalanine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Ajinomoto (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Kyowa Hakko Bio (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hebei Huayang Biological Technology Co (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Wuxi Jinghai Amino Acid Co Ltd (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Zhangjiagang Huachang Pharmaceutical (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Livzon Pharmaceutical Group (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Piping Rock (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Twinlab Consolidated Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Solgar (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. BlueBonnet (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global L-Phenylalanine Sale, by Type, Application, End-User , Distribution Channel, Different Treatments and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global L-Phenylalanine (Value)
      • 7.2.1. Global L-Phenylalanine by: Type (Value)
        • 7.2.1.1. Food Grade
        • 7.2.1.2. Pharmaceutical Grade
        • 7.2.1.3. Nutraceutical
        • 7.2.1.4. Industrial Grade
      • 7.2.2. Global L-Phenylalanine by: Application (Value)
        • 7.2.2.1. Food
        • 7.2.2.2. Medicine
        • 7.2.2.3. Supplements
        • 7.2.2.4. Others
      • 7.2.3. Global L-Phenylalanine by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global L-Phenylalanine by: Different Treatments (Value)
        • 7.2.4.1. Depression
        • 7.2.4.2. Attention Deficit-Hyperactivity Disorder
        • 7.2.4.3. Parkinson's Disease
        • 7.2.4.4. Chronic Pain
        • 7.2.4.5. Osteoarthritis
        • 7.2.4.6. Rheumatoid Arthritis
      • 7.2.5. Global L-Phenylalanine Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global L-Phenylalanine (Volume)
      • 7.3.1. Global L-Phenylalanine by: Type (Volume)
        • 7.3.1.1. Food Grade
        • 7.3.1.2. Pharmaceutical Grade
        • 7.3.1.3. Nutraceutical
        • 7.3.1.4. Industrial Grade
      • 7.3.2. Global L-Phenylalanine by: Application (Volume)
        • 7.3.2.1. Food
        • 7.3.2.2. Medicine
        • 7.3.2.3. Supplements
        • 7.3.2.4. Others
      • 7.3.3. Global L-Phenylalanine by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global L-Phenylalanine by: Different Treatments (Volume)
        • 7.3.4.1. Depression
        • 7.3.4.2. Attention Deficit-Hyperactivity Disorder
        • 7.3.4.3. Parkinson's Disease
        • 7.3.4.4. Chronic Pain
        • 7.3.4.5. Osteoarthritis
        • 7.3.4.6. Rheumatoid Arthritis
      • 7.3.5. Global L-Phenylalanine Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global L-Phenylalanine (Price)
      • 7.4.1. Global L-Phenylalanine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. L-Phenylalanine: by Type(USD Million)
  • Table 2. L-Phenylalanine Food Grade , by Region USD Million (2018-2023)
  • Table 3. L-Phenylalanine Pharmaceutical Grade , by Region USD Million (2018-2023)
  • Table 4. L-Phenylalanine Nutraceutical , by Region USD Million (2018-2023)
  • Table 5. L-Phenylalanine Industrial Grade , by Region USD Million (2018-2023)
  • Table 6. L-Phenylalanine: by Application(USD Million)
  • Table 7. L-Phenylalanine Food , by Region USD Million (2018-2023)
  • Table 8. L-Phenylalanine Medicine , by Region USD Million (2018-2023)
  • Table 9. L-Phenylalanine Supplements , by Region USD Million (2018-2023)
  • Table 10. L-Phenylalanine Others , by Region USD Million (2018-2023)
  • Table 11. L-Phenylalanine: by Distribution Channel(USD Million)
  • Table 12. L-Phenylalanine Online , by Region USD Million (2018-2023)
  • Table 13. L-Phenylalanine Offline , by Region USD Million (2018-2023)
  • Table 14. L-Phenylalanine: by Different Treatments(USD Million)
  • Table 15. L-Phenylalanine Depression , by Region USD Million (2018-2023)
  • Table 16. L-Phenylalanine Attention Deficit-Hyperactivity Disorder , by Region USD Million (2018-2023)
  • Table 17. L-Phenylalanine Parkinson's Disease , by Region USD Million (2018-2023)
  • Table 18. L-Phenylalanine Chronic Pain , by Region USD Million (2018-2023)
  • Table 19. L-Phenylalanine Osteoarthritis , by Region USD Million (2018-2023)
  • Table 20. L-Phenylalanine Rheumatoid Arthritis , by Region USD Million (2018-2023)
  • Table 21. South America L-Phenylalanine, by Country USD Million (2018-2023)
  • Table 22. South America L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 23. South America L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 24. South America L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 25. South America L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 26. South America L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 27. Brazil L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 28. Brazil L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 29. Brazil L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 30. Brazil L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 31. Brazil L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 32. Argentina L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 33. Argentina L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 34. Argentina L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 35. Argentina L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 36. Argentina L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 37. Rest of South America L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 38. Rest of South America L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 39. Rest of South America L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 40. Rest of South America L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 41. Rest of South America L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 42. Asia Pacific L-Phenylalanine, by Country USD Million (2018-2023)
  • Table 43. Asia Pacific L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 44. Asia Pacific L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 45. Asia Pacific L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 46. Asia Pacific L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 47. Asia Pacific L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 48. China L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 49. China L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 50. China L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 51. China L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 52. China L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 53. Japan L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 54. Japan L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 55. Japan L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 56. Japan L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 57. Japan L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 58. India L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 59. India L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 60. India L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 61. India L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 62. India L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 63. South Korea L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 64. South Korea L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 65. South Korea L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 66. South Korea L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 67. South Korea L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 68. Taiwan L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 69. Taiwan L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 70. Taiwan L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 71. Taiwan L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 72. Taiwan L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 73. Australia L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 74. Australia L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 75. Australia L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 76. Australia L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 77. Australia L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 78. Rest of Asia-Pacific L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 79. Rest of Asia-Pacific L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 80. Rest of Asia-Pacific L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 81. Rest of Asia-Pacific L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 82. Rest of Asia-Pacific L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 83. Europe L-Phenylalanine, by Country USD Million (2018-2023)
  • Table 84. Europe L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 85. Europe L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 86. Europe L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 87. Europe L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 88. Europe L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 89. Germany L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 90. Germany L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 91. Germany L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 92. Germany L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 93. Germany L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 94. France L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 95. France L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 96. France L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 97. France L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 98. France L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 99. Italy L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 100. Italy L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 101. Italy L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 102. Italy L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 103. Italy L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 104. United Kingdom L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 105. United Kingdom L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 106. United Kingdom L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 107. United Kingdom L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 108. United Kingdom L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 109. Netherlands L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 110. Netherlands L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 111. Netherlands L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 112. Netherlands L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 113. Netherlands L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 114. Rest of Europe L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 115. Rest of Europe L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 116. Rest of Europe L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 117. Rest of Europe L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 118. Rest of Europe L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 119. MEA L-Phenylalanine, by Country USD Million (2018-2023)
  • Table 120. MEA L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 121. MEA L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 122. MEA L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 123. MEA L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 124. MEA L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 125. Middle East L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 126. Middle East L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 127. Middle East L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 128. Middle East L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 129. Middle East L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 130. Africa L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 131. Africa L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 132. Africa L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 133. Africa L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 134. Africa L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 135. North America L-Phenylalanine, by Country USD Million (2018-2023)
  • Table 136. North America L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 137. North America L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 138. North America L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 139. North America L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 140. North America L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 141. United States L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 142. United States L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 143. United States L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 144. United States L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 145. United States L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 146. Canada L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 147. Canada L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 148. Canada L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 149. Canada L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 150. Canada L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 151. Mexico L-Phenylalanine, by Type USD Million (2018-2023)
  • Table 152. Mexico L-Phenylalanine, by Application USD Million (2018-2023)
  • Table 153. Mexico L-Phenylalanine, by End-User USD Million (2018-2023)
  • Table 154. Mexico L-Phenylalanine, by Distribution Channel USD Million (2018-2023)
  • Table 155. Mexico L-Phenylalanine, by Different Treatments USD Million (2018-2023)
  • Table 156. L-Phenylalanine Sales: by Type(K Units)
  • Table 157. L-Phenylalanine Sales Food Grade , by Region K Units (2018-2023)
  • Table 158. L-Phenylalanine Sales Pharmaceutical Grade , by Region K Units (2018-2023)
  • Table 159. L-Phenylalanine Sales Nutraceutical , by Region K Units (2018-2023)
  • Table 160. L-Phenylalanine Sales Industrial Grade , by Region K Units (2018-2023)
  • Table 161. L-Phenylalanine Sales: by Application(K Units)
  • Table 162. L-Phenylalanine Sales Food , by Region K Units (2018-2023)
  • Table 163. L-Phenylalanine Sales Medicine , by Region K Units (2018-2023)
  • Table 164. L-Phenylalanine Sales Supplements , by Region K Units (2018-2023)
  • Table 165. L-Phenylalanine Sales Others , by Region K Units (2018-2023)
  • Table 166. L-Phenylalanine Sales: by Distribution Channel(K Units)
  • Table 167. L-Phenylalanine Sales Online , by Region K Units (2018-2023)
  • Table 168. L-Phenylalanine Sales Offline , by Region K Units (2018-2023)
  • Table 169. L-Phenylalanine Sales: by Different Treatments(K Units)
  • Table 170. L-Phenylalanine Sales Depression , by Region K Units (2018-2023)
  • Table 171. L-Phenylalanine Sales Attention Deficit-Hyperactivity Disorder , by Region K Units (2018-2023)
  • Table 172. L-Phenylalanine Sales Parkinson's Disease , by Region K Units (2018-2023)
  • Table 173. L-Phenylalanine Sales Chronic Pain , by Region K Units (2018-2023)
  • Table 174. L-Phenylalanine Sales Osteoarthritis , by Region K Units (2018-2023)
  • Table 175. L-Phenylalanine Sales Rheumatoid Arthritis , by Region K Units (2018-2023)
  • Table 176. South America L-Phenylalanine Sales, by Country K Units (2018-2023)
  • Table 177. South America L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 178. South America L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 179. South America L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 180. South America L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 181. South America L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 182. Brazil L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 183. Brazil L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 184. Brazil L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 185. Brazil L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 186. Brazil L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 187. Argentina L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 188. Argentina L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 189. Argentina L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 190. Argentina L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 191. Argentina L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 192. Rest of South America L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 193. Rest of South America L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 194. Rest of South America L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 195. Rest of South America L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 196. Rest of South America L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 197. Asia Pacific L-Phenylalanine Sales, by Country K Units (2018-2023)
  • Table 198. Asia Pacific L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 199. Asia Pacific L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 200. Asia Pacific L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 201. Asia Pacific L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 202. Asia Pacific L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 203. China L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 204. China L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 205. China L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 206. China L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 207. China L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 208. Japan L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 209. Japan L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 210. Japan L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 211. Japan L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 212. Japan L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 213. India L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 214. India L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 215. India L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 216. India L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 217. India L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 218. South Korea L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 219. South Korea L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 220. South Korea L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 221. South Korea L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 222. South Korea L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 223. Taiwan L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 224. Taiwan L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 225. Taiwan L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 226. Taiwan L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 227. Taiwan L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 228. Australia L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 229. Australia L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 230. Australia L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 231. Australia L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 232. Australia L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 233. Rest of Asia-Pacific L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 234. Rest of Asia-Pacific L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 235. Rest of Asia-Pacific L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 236. Rest of Asia-Pacific L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 237. Rest of Asia-Pacific L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 238. Europe L-Phenylalanine Sales, by Country K Units (2018-2023)
  • Table 239. Europe L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 240. Europe L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 241. Europe L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 242. Europe L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 243. Europe L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 244. Germany L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 245. Germany L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 246. Germany L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 247. Germany L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 248. Germany L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 249. France L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 250. France L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 251. France L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 252. France L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 253. France L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 254. Italy L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 255. Italy L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 256. Italy L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 257. Italy L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 258. Italy L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 259. United Kingdom L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 260. United Kingdom L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 261. United Kingdom L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 262. United Kingdom L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 263. United Kingdom L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 264. Netherlands L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 265. Netherlands L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 266. Netherlands L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 267. Netherlands L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 268. Netherlands L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 269. Rest of Europe L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 270. Rest of Europe L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 271. Rest of Europe L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 272. Rest of Europe L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 273. Rest of Europe L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 274. MEA L-Phenylalanine Sales, by Country K Units (2018-2023)
  • Table 275. MEA L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 276. MEA L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 277. MEA L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 278. MEA L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 279. MEA L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 280. Middle East L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 281. Middle East L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 282. Middle East L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 283. Middle East L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 284. Middle East L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 285. Africa L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 286. Africa L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 287. Africa L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 288. Africa L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 289. Africa L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 290. North America L-Phenylalanine Sales, by Country K Units (2018-2023)
  • Table 291. North America L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 292. North America L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 293. North America L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 294. North America L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 295. North America L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 296. United States L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 297. United States L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 298. United States L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 299. United States L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 300. United States L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 301. Canada L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 302. Canada L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 303. Canada L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 304. Canada L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 305. Canada L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 306. Mexico L-Phenylalanine Sales, by Type K Units (2018-2023)
  • Table 307. Mexico L-Phenylalanine Sales, by Application K Units (2018-2023)
  • Table 308. Mexico L-Phenylalanine Sales, by End-User K Units (2018-2023)
  • Table 309. Mexico L-Phenylalanine Sales, by Distribution Channel K Units (2018-2023)
  • Table 310. Mexico L-Phenylalanine Sales, by Different Treatments K Units (2018-2023)
  • Table 311. L-Phenylalanine: by Type(USD/Units)
  • Table 312. Company Basic Information, Sales Area and Its Competitors
  • Table 313. Company Basic Information, Sales Area and Its Competitors
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Company Basic Information, Sales Area and Its Competitors
  • Table 316. Company Basic Information, Sales Area and Its Competitors
  • Table 317. Company Basic Information, Sales Area and Its Competitors
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. L-Phenylalanine: by Type(USD Million)
  • Table 323. L-Phenylalanine Food Grade , by Region USD Million (2025-2030)
  • Table 324. L-Phenylalanine Pharmaceutical Grade , by Region USD Million (2025-2030)
  • Table 325. L-Phenylalanine Nutraceutical , by Region USD Million (2025-2030)
  • Table 326. L-Phenylalanine Industrial Grade , by Region USD Million (2025-2030)
  • Table 327. L-Phenylalanine: by Application(USD Million)
  • Table 328. L-Phenylalanine Food , by Region USD Million (2025-2030)
  • Table 329. L-Phenylalanine Medicine , by Region USD Million (2025-2030)
  • Table 330. L-Phenylalanine Supplements , by Region USD Million (2025-2030)
  • Table 331. L-Phenylalanine Others , by Region USD Million (2025-2030)
  • Table 332. L-Phenylalanine: by Distribution Channel(USD Million)
  • Table 333. L-Phenylalanine Online , by Region USD Million (2025-2030)
  • Table 334. L-Phenylalanine Offline , by Region USD Million (2025-2030)
  • Table 335. L-Phenylalanine: by Different Treatments(USD Million)
  • Table 336. L-Phenylalanine Depression , by Region USD Million (2025-2030)
  • Table 337. L-Phenylalanine Attention Deficit-Hyperactivity Disorder , by Region USD Million (2025-2030)
  • Table 338. L-Phenylalanine Parkinson's Disease , by Region USD Million (2025-2030)
  • Table 339. L-Phenylalanine Chronic Pain , by Region USD Million (2025-2030)
  • Table 340. L-Phenylalanine Osteoarthritis , by Region USD Million (2025-2030)
  • Table 341. L-Phenylalanine Rheumatoid Arthritis , by Region USD Million (2025-2030)
  • Table 342. South America L-Phenylalanine, by Country USD Million (2025-2030)
  • Table 343. South America L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 344. South America L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 345. South America L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 346. South America L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 347. South America L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 348. Brazil L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 349. Brazil L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 350. Brazil L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 351. Brazil L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 352. Brazil L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 353. Argentina L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 354. Argentina L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 355. Argentina L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 356. Argentina L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 357. Argentina L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 358. Rest of South America L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 359. Rest of South America L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 360. Rest of South America L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 361. Rest of South America L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 362. Rest of South America L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 363. Asia Pacific L-Phenylalanine, by Country USD Million (2025-2030)
  • Table 364. Asia Pacific L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 365. Asia Pacific L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 366. Asia Pacific L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 367. Asia Pacific L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 368. Asia Pacific L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 369. China L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 370. China L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 371. China L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 372. China L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 373. China L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 374. Japan L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 375. Japan L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 376. Japan L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 377. Japan L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 378. Japan L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 379. India L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 380. India L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 381. India L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 382. India L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 383. India L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 384. South Korea L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 385. South Korea L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 386. South Korea L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 387. South Korea L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 388. South Korea L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 389. Taiwan L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 390. Taiwan L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 391. Taiwan L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 392. Taiwan L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 393. Taiwan L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 394. Australia L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 395. Australia L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 396. Australia L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 397. Australia L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 398. Australia L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 399. Rest of Asia-Pacific L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 400. Rest of Asia-Pacific L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 401. Rest of Asia-Pacific L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 402. Rest of Asia-Pacific L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 403. Rest of Asia-Pacific L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 404. Europe L-Phenylalanine, by Country USD Million (2025-2030)
  • Table 405. Europe L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 406. Europe L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 407. Europe L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 408. Europe L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 409. Europe L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 410. Germany L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 411. Germany L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 412. Germany L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 413. Germany L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 414. Germany L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 415. France L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 416. France L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 417. France L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 418. France L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 419. France L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 420. Italy L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 421. Italy L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 422. Italy L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 423. Italy L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 424. Italy L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 425. United Kingdom L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 426. United Kingdom L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 427. United Kingdom L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 428. United Kingdom L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 429. United Kingdom L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 430. Netherlands L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 431. Netherlands L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 432. Netherlands L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 433. Netherlands L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 434. Netherlands L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 435. Rest of Europe L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 436. Rest of Europe L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 437. Rest of Europe L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 438. Rest of Europe L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 439. Rest of Europe L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 440. MEA L-Phenylalanine, by Country USD Million (2025-2030)
  • Table 441. MEA L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 442. MEA L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 443. MEA L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 444. MEA L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 445. MEA L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 446. Middle East L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 447. Middle East L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 448. Middle East L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 449. Middle East L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 450. Middle East L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 451. Africa L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 452. Africa L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 453. Africa L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 454. Africa L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 455. Africa L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 456. North America L-Phenylalanine, by Country USD Million (2025-2030)
  • Table 457. North America L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 458. North America L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 459. North America L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 460. North America L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 461. North America L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 462. United States L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 463. United States L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 464. United States L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 465. United States L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 466. United States L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 467. Canada L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 468. Canada L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 469. Canada L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 470. Canada L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 471. Canada L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 472. Mexico L-Phenylalanine, by Type USD Million (2025-2030)
  • Table 473. Mexico L-Phenylalanine, by Application USD Million (2025-2030)
  • Table 474. Mexico L-Phenylalanine, by End-User USD Million (2025-2030)
  • Table 475. Mexico L-Phenylalanine, by Distribution Channel USD Million (2025-2030)
  • Table 476. Mexico L-Phenylalanine, by Different Treatments USD Million (2025-2030)
  • Table 477. L-Phenylalanine Sales: by Type(K Units)
  • Table 478. L-Phenylalanine Sales Food Grade , by Region K Units (2025-2030)
  • Table 479. L-Phenylalanine Sales Pharmaceutical Grade , by Region K Units (2025-2030)
  • Table 480. L-Phenylalanine Sales Nutraceutical , by Region K Units (2025-2030)
  • Table 481. L-Phenylalanine Sales Industrial Grade , by Region K Units (2025-2030)
  • Table 482. L-Phenylalanine Sales: by Application(K Units)
  • Table 483. L-Phenylalanine Sales Food , by Region K Units (2025-2030)
  • Table 484. L-Phenylalanine Sales Medicine , by Region K Units (2025-2030)
  • Table 485. L-Phenylalanine Sales Supplements , by Region K Units (2025-2030)
  • Table 486. L-Phenylalanine Sales Others , by Region K Units (2025-2030)
  • Table 487. L-Phenylalanine Sales: by Distribution Channel(K Units)
  • Table 488. L-Phenylalanine Sales Online , by Region K Units (2025-2030)
  • Table 489. L-Phenylalanine Sales Offline , by Region K Units (2025-2030)
  • Table 490. L-Phenylalanine Sales: by Different Treatments(K Units)
  • Table 491. L-Phenylalanine Sales Depression , by Region K Units (2025-2030)
  • Table 492. L-Phenylalanine Sales Attention Deficit-Hyperactivity Disorder , by Region K Units (2025-2030)
  • Table 493. L-Phenylalanine Sales Parkinson's Disease , by Region K Units (2025-2030)
  • Table 494. L-Phenylalanine Sales Chronic Pain , by Region K Units (2025-2030)
  • Table 495. L-Phenylalanine Sales Osteoarthritis , by Region K Units (2025-2030)
  • Table 496. L-Phenylalanine Sales Rheumatoid Arthritis , by Region K Units (2025-2030)
  • Table 497. South America L-Phenylalanine Sales, by Country K Units (2025-2030)
  • Table 498. South America L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 499. South America L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 500. South America L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 501. South America L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 502. South America L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 503. Brazil L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 504. Brazil L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 505. Brazil L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 506. Brazil L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 507. Brazil L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 508. Argentina L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 509. Argentina L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 510. Argentina L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 511. Argentina L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 512. Argentina L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 513. Rest of South America L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 514. Rest of South America L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 515. Rest of South America L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 516. Rest of South America L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 517. Rest of South America L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 518. Asia Pacific L-Phenylalanine Sales, by Country K Units (2025-2030)
  • Table 519. Asia Pacific L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 520. Asia Pacific L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 521. Asia Pacific L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 522. Asia Pacific L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 523. Asia Pacific L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 524. China L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 525. China L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 526. China L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 527. China L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 528. China L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 529. Japan L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 530. Japan L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 531. Japan L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 532. Japan L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 533. Japan L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 534. India L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 535. India L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 536. India L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 537. India L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 538. India L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 539. South Korea L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 540. South Korea L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 541. South Korea L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 542. South Korea L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 543. South Korea L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 544. Taiwan L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 545. Taiwan L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 546. Taiwan L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 547. Taiwan L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 548. Taiwan L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 549. Australia L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 550. Australia L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 551. Australia L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 552. Australia L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 553. Australia L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 554. Rest of Asia-Pacific L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 555. Rest of Asia-Pacific L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 556. Rest of Asia-Pacific L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 557. Rest of Asia-Pacific L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 558. Rest of Asia-Pacific L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 559. Europe L-Phenylalanine Sales, by Country K Units (2025-2030)
  • Table 560. Europe L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 561. Europe L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 562. Europe L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 563. Europe L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 564. Europe L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 565. Germany L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 566. Germany L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 567. Germany L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 568. Germany L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 569. Germany L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 570. France L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 571. France L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 572. France L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 573. France L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 574. France L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 575. Italy L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 576. Italy L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 577. Italy L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 578. Italy L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 579. Italy L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 580. United Kingdom L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 581. United Kingdom L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 582. United Kingdom L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 583. United Kingdom L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 584. United Kingdom L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 585. Netherlands L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 586. Netherlands L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 587. Netherlands L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 588. Netherlands L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 589. Netherlands L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 590. Rest of Europe L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 591. Rest of Europe L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 592. Rest of Europe L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 593. Rest of Europe L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 594. Rest of Europe L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 595. MEA L-Phenylalanine Sales, by Country K Units (2025-2030)
  • Table 596. MEA L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 597. MEA L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 598. MEA L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 599. MEA L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 600. MEA L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 601. Middle East L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 602. Middle East L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 603. Middle East L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 604. Middle East L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 605. Middle East L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 606. Africa L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 607. Africa L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 608. Africa L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 609. Africa L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 610. Africa L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 611. North America L-Phenylalanine Sales, by Country K Units (2025-2030)
  • Table 612. North America L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 613. North America L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 614. North America L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 615. North America L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 616. North America L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 617. United States L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 618. United States L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 619. United States L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 620. United States L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 621. United States L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 622. Canada L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 623. Canada L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 624. Canada L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 625. Canada L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 626. Canada L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 627. Mexico L-Phenylalanine Sales, by Type K Units (2025-2030)
  • Table 628. Mexico L-Phenylalanine Sales, by Application K Units (2025-2030)
  • Table 629. Mexico L-Phenylalanine Sales, by End-User K Units (2025-2030)
  • Table 630. Mexico L-Phenylalanine Sales, by Distribution Channel K Units (2025-2030)
  • Table 631. Mexico L-Phenylalanine Sales, by Different Treatments K Units (2025-2030)
  • Table 632. L-Phenylalanine: by Type(USD/Units)
  • Table 633. Research Programs/Design for This Report
  • Table 634. Key Data Information from Secondary Sources
  • Table 635. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global L-Phenylalanine: by Type USD Million (2018-2023)
  • Figure 5. Global L-Phenylalanine: by Application USD Million (2018-2023)
  • Figure 6. Global L-Phenylalanine: by Distribution Channel USD Million (2018-2023)
  • Figure 7. Global L-Phenylalanine: by Different Treatments USD Million (2018-2023)
  • Figure 8. South America L-Phenylalanine Share (%), by Country
  • Figure 9. Asia Pacific L-Phenylalanine Share (%), by Country
  • Figure 10. Europe L-Phenylalanine Share (%), by Country
  • Figure 11. MEA L-Phenylalanine Share (%), by Country
  • Figure 12. North America L-Phenylalanine Share (%), by Country
  • Figure 13. Global L-Phenylalanine: by Type K Units (2018-2023)
  • Figure 14. Global L-Phenylalanine: by Application K Units (2018-2023)
  • Figure 15. Global L-Phenylalanine: by Distribution Channel K Units (2018-2023)
  • Figure 16. Global L-Phenylalanine: by Different Treatments K Units (2018-2023)
  • Figure 17. South America L-Phenylalanine Share (%), by Country
  • Figure 18. Asia Pacific L-Phenylalanine Share (%), by Country
  • Figure 19. Europe L-Phenylalanine Share (%), by Country
  • Figure 20. MEA L-Phenylalanine Share (%), by Country
  • Figure 21. North America L-Phenylalanine Share (%), by Country
  • Figure 22. Global L-Phenylalanine: by Type USD/Units (2018-2023)
  • Figure 23. Global L-Phenylalanine share by Players 2023 (%)
  • Figure 24. Global L-Phenylalanine share by Players (Top 3) 2023(%)
  • Figure 25. Global L-Phenylalanine share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Ajinomoto (Japan) Revenue, Net Income and Gross profit
  • Figure 28. Ajinomoto (Japan) Revenue: by Geography 2023
  • Figure 29. Kyowa Hakko Bio (India) Revenue, Net Income and Gross profit
  • Figure 30. Kyowa Hakko Bio (India) Revenue: by Geography 2023
  • Figure 31. Hebei Huayang Biological Technology Co (China) Revenue, Net Income and Gross profit
  • Figure 32. Hebei Huayang Biological Technology Co (China) Revenue: by Geography 2023
  • Figure 33. Wuxi Jinghai Amino Acid Co Ltd (China) Revenue, Net Income and Gross profit
  • Figure 34. Wuxi Jinghai Amino Acid Co Ltd (China) Revenue: by Geography 2023
  • Figure 35. Zhangjiagang Huachang Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 36. Zhangjiagang Huachang Pharmaceutical (China) Revenue: by Geography 2023
  • Figure 37. Livzon Pharmaceutical Group (China) Revenue, Net Income and Gross profit
  • Figure 38. Livzon Pharmaceutical Group (China) Revenue: by Geography 2023
  • Figure 39. Piping Rock (United States) Revenue, Net Income and Gross profit
  • Figure 40. Piping Rock (United States) Revenue: by Geography 2023
  • Figure 41. Twinlab Consolidated Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. Twinlab Consolidated Corporation (United States) Revenue: by Geography 2023
  • Figure 43. Solgar (United States) Revenue, Net Income and Gross profit
  • Figure 44. Solgar (United States) Revenue: by Geography 2023
  • Figure 45. BlueBonnet (United States) Revenue, Net Income and Gross profit
  • Figure 46. BlueBonnet (United States) Revenue: by Geography 2023
  • Figure 47. Global L-Phenylalanine: by Type USD Million (2025-2030)
  • Figure 48. Global L-Phenylalanine: by Application USD Million (2025-2030)
  • Figure 49. Global L-Phenylalanine: by Distribution Channel USD Million (2025-2030)
  • Figure 50. Global L-Phenylalanine: by Different Treatments USD Million (2025-2030)
  • Figure 51. South America L-Phenylalanine Share (%), by Country
  • Figure 52. Asia Pacific L-Phenylalanine Share (%), by Country
  • Figure 53. Europe L-Phenylalanine Share (%), by Country
  • Figure 54. MEA L-Phenylalanine Share (%), by Country
  • Figure 55. North America L-Phenylalanine Share (%), by Country
  • Figure 56. Global L-Phenylalanine: by Type K Units (2025-2030)
  • Figure 57. Global L-Phenylalanine: by Application K Units (2025-2030)
  • Figure 58. Global L-Phenylalanine: by Distribution Channel K Units (2025-2030)
  • Figure 59. Global L-Phenylalanine: by Different Treatments K Units (2025-2030)
  • Figure 60. South America L-Phenylalanine Share (%), by Country
  • Figure 61. Asia Pacific L-Phenylalanine Share (%), by Country
  • Figure 62. Europe L-Phenylalanine Share (%), by Country
  • Figure 63. MEA L-Phenylalanine Share (%), by Country
  • Figure 64. North America L-Phenylalanine Share (%), by Country
  • Figure 65. Global L-Phenylalanine: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Ajinomoto (Japan)
  • Kyowa Hakko Bio (India)
  • Hebei Huayang Biological Technology Co (China)
  • Wuxi Jinghai Amino Acid Co Ltd (China)
  • Zhangjiagang Huachang Pharmaceutical (China)
  • Livzon Pharmaceutical Group (China)
  • Piping Rock (United States)
  • Twinlab Consolidated Corporation (United States)
  • Solgar (United States)
  • BlueBonnet (United States)
Additional players considered in the study are as follows:
Jiahe Biotech (China) , Xiyue Pharmaceuticals (China) , Others
Select User Access Type

Key Highlights of Report


Mar 2024 222 Pages 73 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global L-Phenylalanine Quantitative research analysis
Global L-Phenylalanine Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Ajinomoto (Japan), Kyowa Hakko Bio (India), Hebei Huayang Biological Technology Co (China), Wuxi Jinghai Amino Acid Co Ltd (China), Zhangjiagang Huachang Pharmaceutical (China), Livzon Pharmaceutical Group (China), Piping Rock (United States), Twinlab Consolidated Corporation (United States), Solgar (United States) and BlueBonnet (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"It is Highly Demanded as Supplement as Only Amino Acids Have Proteins" is seen as one of major influencing trends for L-Phenylalanine Market during projected period 2023-2030.
The L-Phenylalanine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global L-Phenylalanine Report?

Have a Query? Click Here

Other Related Reports

Graphite oxide Comprehensive Study by Type (Powder-Based Graphene Oxide, Solution Based Graphene Oxide), Application (Medical, Energy, Electronic devices, Composites materials, Catalytic oxidation, O...
$ 3350
Hospital Cleaning Chemicals Comprehensive Study by Type (Bleach, Disinfectants(Quaternary Ammonium, Hypochlorite, Phenolics, Peracetic Acid and Others), Others), Application (Surfaces, Equipment, Pat...
$ 3750
Ultra-Pure Sulphuric Acid Comprehensive Study by Type (95% Concentration, 96% Concentration, 98% Concentration, Other), Application (Semiconductors, Industrial Chemicals, Printed Circuit Boards, Othe...
$ 3450
Lithium Formate Comprehensive Study by Type (98% Purity, 99% Purity), Application (Intensity Modulation Radiation Therapy (IMRT), Electron Paramagnetic Resonance Imaging (EPRI)), End Users (Health Ca...
$ 3500
Calcium Phytate Comprehensive Study by Type (Pharmaceutical Grade, Food Grade), Application (Food, Greases, Pharmaceuticals, Others), Purity (≥ 95.0%, < 95.0%), Sales Channel (Direct, Indirect)...
$ 3500
Acetyl-L Carnitine (ALC) Comprehensive Study by Application (Healthcare, Pharmaceutical, Others), Form (Capsule, Tablets, Powder) Players and Region - Global Market Outlook to 2028
$ 3500